IMI Members
Media coverage
2013
- Nature, Careers, 17 April 2013
Regulatory science: Researchers in the pipeline
- Chemistry World, 13 March 2013
Antibiotic resistance is a ‘ticking time bomb’
- EurActiv, 13 March 2013
EU body may provide ‘solution’ to antibiotics resistance threat, says UK medical chief - Quality Net, 13 March 2013
Ισχυρά μικρόβια εναντίον ανήμπορων αντιβιοτικών / Strong antibiotics helpless against germs
- The Guardian, 11 March 2013
New wave of 'superbugs' poses dire threat, says chief medical officer
- BBC, 11 March 2013
Antibiotics resistance 'as big a risk as terrorism' - medical chief - Independent.ie, 11 March 2013
Resistance to antibiotics risks health 'catastrophe' to rank with terrorism and climate change
- Talouselama, 11 March 2013
Globaali aikapommi uhkaa terveydenhoidossa - "samanlainen kansakunnan uhka kuin terrorismikin" / Global time bomb threatening to health care - "similar to the nation as the threat of terrorism"
- Profesia Pravda , 5 March 2013
Univerzita Komenského prispieva k špičkovému vzdelávaniu o liekoch / University contributes to the excellent education about medicines
- DW, Spectrum, 4 March 2013
Make drugs not war
- Melodika, 3 March 2013
Chemaxon provides chemistry informatics platform for the European Lead Factory
- Pharmaceutisch Weekblad, 27 February 2013
Europa en farmabedrijven investeren in nieuwe antibiotica
- Idw Online, 22 February 2013
Medikamente von Grund auf neu entwickeln - La gazette du laboratoire, 22 February 2013
Un nouveau pas dans la lutte contre les résistances aux antibiotiques - Süedkurier, 18 February 2013
Infos über Pharmabranche - Scrip Intelligence, 11 February 2013
Bayer leads seven Big Pharmas in €196m European Lead Factory - Medical Tribune, 11 February 2013
IMI – cesta k partnerství při výzkumu i realizaci / IMI - the path to partnership in research and implementation - European Biotechnology News, 8 February 2013
IMI launches €196m project - European Pharmaceutical Review, 7 February 2013
€196 million Pan-European drug discovery platform launched - Eurip cities, February 2013
Neue Hoffnung im Kampf gegen multiresistente - Pharma Times, 7 February 2013
EU 196 million euro drug discovery consortium launched - MEDportal.Ru, 7 February 2013
Europe will spend almost 200 million euros on a new generation of drugs - Drug Information Online (Drugs.com), February 2013
Bayer supports innovative drug discovery in Europe - CHEManager, 7 February 2013
Drugmakers, Academics Pool R&D in $265 Million EU Project - World Pharma News, 7 February 2013
€196 million pan-European drug discovery platform launched - Equities.com, February 2013
European Innovative Medicines Initiative (IMI); Bayer supports innovative drug discovery in Europe; Bayer HealthCare to coordinate international consortium "European Lead Factory" aiming at jointly discovering new medicines - Medical Technology Business Europe, 7 February 2013
BioCity Scotland to be UK hub for €196m European drug discovery project - Fierce Biotech, 7 February 2013
€196 million pan-European drug discovery platform launched - Scottish Government, 7 February 2013
Lanarkshire and Dundee in £100M life science project - Nature, 7 February 2013
Europe bets on drug discovery - Reuters, 7 February 2013
Drugmakers, academics pool R&D in $265 mln EU project - BBC, 7 February 2013
Scottish consortium wins £100m drug research contract - Nature Biotechnology, 7 February 2013
Industry backs biocatalysis for greener manufacturing - The Guardian, 27 January 2013
Science funding and the EU: you've got to be in it to win it - Bio Century, 24 January 2013
IMI's collaborative chemistry - Nature Biotechnology, January 2013
Banking iPS cells - Nature Reviews Drug Discovery, January 2013
News and Analysis - 2012 in reflection
2012
- Pharmatimes, published online December 2012
IMI and rethinking the R&D paradigm - Pan European Networks, published online 11 December 2012
Innovative injections - British Medical Journal, published online 7 December 2012
New €55.6m European project will use stem cells to increase understanding of diseases - Financial Times, published online 5 December 2012
UK to lead stem cell research project - The Wall Street Journal, published online 5 December 2012
Drug Makers, Universities Team Up on Stem Cells - Reuters, 5 December 2012
European stem cell bank aims to speed drug development - Nature, News Blog, 5 December 2012
€50 million project aims to produce 1,500 stem cell lines for drug discovery - MedNous, November/December 2012
As Big Pharma pulls back, IMI steps in - Deutschland Radio Kultur, 8 November 2012
Interview with Michel Goldman about antimicrobial resistance - European Voice, November 2012
Public-private partnerships are the way forward to improve drug safety – the example of the Innovative Medicines Initiative - Deutsch Welle, October 2012
New future with pre-competitive science - Nature Biotechnology, 7 August 2012
Incentives aim to boost antibiotic development - The Lancet, 15 June 2012
Europe to boost development of new antimicrobial drugs - Biocentury, 4 June 2012
Innovating Antibiotics - Parliament Magazine, 28 May 2012
Joint Action - Financial Times, 27 May 2012
Public health: Raised resistance - The Wall Street Journal, 24 May 2012
EU joins widening push to find new antibiotics - The Guardian, 24 May 2012
GlaxoSmithKline and AstraZeneca invest in biotech research - The Times, 24 May 2012
Drugs giants put rivalries aside to tackle the scourge of the superbug - Nature News, 24 May 2012
Europe targets superbugs with public-private effort - Scrip, 24 May 2012
IMI launches €224m R&D programme to tackle antibiotics resistance - Parliament Magazine, 10 May 2012
Public private partnerships key to growth of EU pharma research - Science-Business eXchange, 10 May 2012
A mind for precompetitive collaboration - Science-Business eXchange, 19 April 2012
Building tools against autism - Nature Medicine, 5 April 2012
Europe plans molecular screening center for translational research - Science-Business eXchange, 29 March 2012
IMI's leadoff hitter - Nature, 27 March 2012
Chemistry’s web of data expands - InPharm, 12 March 2012
UCB chief executive to chair IMI - SCRIP Intelligence, 8 March 2012
Seven pharma fuel €170m EU-wide screening honeypot - Pharma Times, 8 March 2012
IMI to set up European Lead Factory for new drug opportunities - Pharma Times, 8 March 2012
UCB chief Doliveux to head IMI - PharmaNews, 8 March 2012
IMI funds platform to discover new medicines - PMLiVE, 7 March 2012
Europe's IMI plans compound library and screening centre - Microbiology Today, February 2012 (p.55)
IMI to launch major antimicrobial resistance project - Science Translational Medicines, February 2012
Recalibrating Intellectual Property Rights to Enhance Translational Research Collaborations - Nature, 12 January 2012
Rules tighten on use of antibiotics on farms - Innovation Excellence, 6 January 2012
Open Innovation, Technology Platforms and a New Business Model- All-in-One Biggie!
Video coverage
- RTBF, 25 May 2012
Les bactéries, Le Point avec l’invité Dr. Michel Goldman - SkyNews, 24 May 2012
Drug Companies Unite in Battle Against Bugs - Video, March 2012
- 'Join forces to unleash creative potential’ – Roch Doliveux, IMI Governing Board Chair
2011
- Pharma Times, 20 December 2011
IMI, CDISC hook up for standardised data management - Bio-IT World, 20 December 2011
CDISC and IMI Sign Standards Agreement - Scrip Intelligence, 9 December 2011
EU launches €80bn R&D plan to cut red tape, create jobs and boost competitiveness - Pharmacuetical Market Europe, 6 December 2011
Interview: Michel Goldman, Innovative Medicines Initiative - TV5Monde, 3 December 2011
Bar de l'Europe - Pharma Times, 1 December 2011
EFPIA welcomes partnership commitment in Horizon 2020 proposal - Science Business Publishing
Open Innovation and Public Policy in Europe - Pharmaceutical Market Europe, December 2011
Interview: Michel Goldman, Innovative Medicines Initiative - Nature Reviews Drug Discovery, December 2011
Expanding precompetitive space (editorial) - Public Service Europe, 28 November 2011
Antibiotics and the future of the pharmaceutical industry - Science Business, 23 November 2011
Commission lures pharma industry back into antibiotics - Nature, 22 November 2011
Antibiotic resistance marching across Europe - Parliament Magazine, 21 November 2011
Joint technology initiatives: Maria da Graça Carvalho - Scrip Intelligence, 18 November 2011
IMI plans "unprecedented" programme for novel antibiotics as drug resistance continues to rise - InPharm, 17 November 2011
Industry supports bid to revitalise antibiotic research - Reuters, 17 November 2011
Europe kickstarts R&D fightback against superbugs - Applied Clinical Trials, 1 November 2011
An Update to Real Innovation - Parliament Magazine Research Review, November 2011
The best medicine (p. 130) - European Federation of Neurological Associations (EFNA), Autumn 2011
Innovative Medicines Initiative (IMI): A revolution in the drug development world - European Voice, 22 September 2011
Pushing at the doors of innovation - Pharmaceutiques, September 2011
L’Initiative medicaments innovants (IMI) - Trends, 1 September 2011
L'IMI, l'agence qui dessine la médecine de demain - BioCentury TV, 31 July 2011
Public + Private Part 2: Turning Great Science into Medicine -- and Jobs - Nature Reviews Drug Discovery, August 2011
Partnering between pharma peers on the rise - Scrip Intelligence, 1 August 2011
EU firms targeted in calls for new biomarkers and drug development tools - BioCentury TV, 24 July 2011
Public + Private: Turning great science into medicine – and Jobs - Science Business, 22 July 2011
Patients take control of innovation - Scrip Intelligence, 15 June 2011
EU IMI and US Critical Path avoid duplication - Science Business, 15 June 2011
EU’s Innovative Medicines Initiative to collaborate with FDA’s Critical Path - Pharma Times, 15 June 2011
US and EU link faster pharma R&D initiatives - Projects, June 2011 (Issue 24)
A new wave of innovative drugs projects (pp. 14-16) - HealthTechWire, 13 May 2011
What is coming next at IMI? - Projects, May 2011 (Issue 23)
Partners in medical innovation (pp. 48-49) - BMJ, 10 March 2011
Europe provides €172m for research into innovative medicines - La Libre Belgique, 9 March 2011
L’union sacrée du secteur pharma - Science Business, 09 March 2011
Maybe Europe’s pharma sector can save itself
2010
- Nature, 11 November 2010
The drug deadlock - Financial Times, 11 June 2010
Drug companies pool Alzheimer’s information - Wallstreet Online DE, 15 June 2010
Joint Venture zwischen EU und Pharmaindustrie ermöglicht 15 Projekte zur Erforschung schwerer Krankheiten - International Innovation, 6 May 2010
Michel Goldman, Executive Director of Innovative Medicines Initiative (IMI) - Irish Times, 3 March 2010
Dip your toe in - Chemical and Engineering News, 22 February 2010
Cracking the Tough Ones - El Medico, January 2010
La Iniciative de Medicamontos Innovadores, un empuje a la investigación europea en fármacos
2009
- Scrip Intelligence, 17 September 2009
Innovative Medicines Initiative to save pharma's floundering R&D model - Euractiv, 15 September 2009
EU to inject millions into developing innovative medicines - Nature Reviews Drug Discovery, July 2009
Novel consortium to address shortfall in innovative medicines for psychiatric disorders - Nature, 20 May 2009
Flagship drug-development initiative picks projects
Innovative Medicines Initiative 2010